Webinar
Accelerate Cardiovascular Device Innovation with FEops' Simulation Technology
From early R&D to first-in-human trials
About this webinar
How can you incorporate the latest trends into your cardiovascular device development? With the growing interest in simulation technology, our FEops acquisition, and recent guidelines on using computational models for regulatory approval in the US and EU markets, now is the perfect time to elevate your R&D with these tools.
FEops' simulation services help you accelerate device development and spark innovation in structural heart and other transcatheter devices — from early R&D to first-in-human trials.
Join this webinar to explore various simulation projects, their places in the product life cycle, and the benefits they offer. You'll also hear customer testimonials from past projects, showcasing their real-world impact.
What you will learn
- The types of simulation technology available and where they bring value within the product life cycle
- What Materialise's acquisition of FEops means for cardiovascular companies
- The impact of simulation technology on previous projects
- How simulation can apply to your project during a live Q&A session
Meet the speakers
Simon Lejaegere
Gianluca De Santis
Francesco Iannaccone
Share on:
L-104446-01